Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness

Recent fndings show that MRP4 is critical for pancreatic ductal adenocarcinoma (PDAC) cell proliferation. Nevertheless, the signifcance of MRP4 protein levels and function in PDAC progression is still unclear. The aim of this study was to determine the role of MRP4 in PDAC tumor aggressiveness. Bioi...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Sahores, A., Carozzo, A., May, M., Gómez, N., Di Siervi, N., De Sousa Serro, M., Yaneff, A., Rodríguez González, A., Abba, Martín Carlos, Shayo, C., Davio, C.
Formato: Articulo
Lenguaje:Inglés
Publicado: 2020
Materias:
Acceso en línea:http://sedici.unlp.edu.ar/handle/10915/107878
http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7450045&blobtype=pdf
https://www.nature.com/articles/s41598-020-71181-w
Aporte de:
id I19-R120-10915-107878
record_format dspace
institution Universidad Nacional de La Plata
institution_str I-19
repository_str R-120
collection SEDICI (UNLP)
language Inglés
topic Medicina
cancer
pancreatic cancer
spellingShingle Medicina
cancer
pancreatic cancer
Sahores, A.
Carozzo, A.
May, M.
Gómez, N.
Di Siervi, N.
De Sousa Serro, M.
Yaneff, A.
Rodríguez González, A.
Abba, Martín Carlos
Shayo, C.
Davio, C.
Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness
topic_facet Medicina
cancer
pancreatic cancer
description Recent fndings show that MRP4 is critical for pancreatic ductal adenocarcinoma (PDAC) cell proliferation. Nevertheless, the signifcance of MRP4 protein levels and function in PDAC progression is still unclear. The aim of this study was to determine the role of MRP4 in PDAC tumor aggressiveness. Bioinformatic studies revealed that PDAC samples show higher MRP4 transcript levels compared to normal adjacent pancreatic tissue and circulating tumor cells express higher levels of MRP4 than primary tumors. Also, high levels of MRP4 are typical of high-grade PDAC cell lines and associate with an epithelial-mesenchymal phenotype. Moreover, PDAC patients with high levels of MRP4 depict dysregulation of pathways associated with migration, chemotaxis and cell adhesion. Silencing MRP4 in PANC1 cells reduced tumorigenicity and tumor growth and impaired cell migration. Transcriptomic analysis revealed that MRP4 silencing alters PANC1 gene expression, mainly dysregulating pathways related to cell-to-cell interactions and focal adhesion. Contrarily, MRP4 overexpression signifcantly increased BxPC-3 growth rate, produced a switch in the expression of EMT markers, and enhanced experimental metastatic incidence. Altogether, our results indicate that MRP4 is associated with a more aggressive phenotype in PDAC, boosting pancreatic tumorigenesis and metastatic capacity, which could fnally determine a fast tumor progression in PDAC patients.
format Articulo
Articulo
author Sahores, A.
Carozzo, A.
May, M.
Gómez, N.
Di Siervi, N.
De Sousa Serro, M.
Yaneff, A.
Rodríguez González, A.
Abba, Martín Carlos
Shayo, C.
Davio, C.
author_facet Sahores, A.
Carozzo, A.
May, M.
Gómez, N.
Di Siervi, N.
De Sousa Serro, M.
Yaneff, A.
Rodríguez González, A.
Abba, Martín Carlos
Shayo, C.
Davio, C.
author_sort Sahores, A.
title Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness
title_short Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness
title_full Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness
title_fullStr Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness
title_full_unstemmed Multidrug transporter MRP4/ABCC4 as a key determinant of pancreatic cancer aggressiveness
title_sort multidrug transporter mrp4/abcc4 as a key determinant of pancreatic cancer aggressiveness
publishDate 2020
url http://sedici.unlp.edu.ar/handle/10915/107878
http://europepmc.org/backend/ptpmcrender.fcgi?accid=PMC7450045&blobtype=pdf
https://www.nature.com/articles/s41598-020-71181-w
work_keys_str_mv AT sahoresa multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
AT carozzoa multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
AT maym multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
AT gomezn multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
AT disiervin multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
AT desousaserrom multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
AT yaneffa multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
AT rodriguezgonzaleza multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
AT abbamartincarlos multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
AT shayoc multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
AT davioc multidrugtransportermrp4abcc4asakeydeterminantofpancreaticcanceraggressiveness
bdutipo_str Repositorios
_version_ 1764820443730018308